Sleep and Circadian Interventions for Suicide

(REST-UP Trial)

DR
TG
Overseen ByTina Goldstein, PhD
Age: 18 - 65
Sex: Any
Trial Phase: Academic
Sponsor: University of Pittsburgh
No Placebo GroupAll trial participants will receive the active study treatment (no placebo)

What You Need to Know Before You Apply

What is the purpose of this trial?

The purpose of this study is to examine the extent to which delivering sleep and circadian focused interventions in addition to evidenced based psychiatric care for depression and suicide risk may contribute to decreasing suicide risk among high risk young adults. Investigators will evaluate three interventions targeting sleep in acutely suicidal college students enrolled in intensive outpatient treatment. Participants will be randomly assigned to one of three intervention groups:

1. Triple Chronotherapy (TCT)+ Transdiagnostic Sleep and Circadian Intervention (TSC)

2. Transdiagnostic Sleep and Circadian Intervention (TSC)

3. Sleep Feedback (SF) Participants will be followed for 6 months with primary outcome domains of suicidal thoughts and behaviors and depression evaluated by blinded clinicians at short (Days 1-4 of intervention), medium (2 months) and long (6 month) term intervals.

Who Is on the Research Team?

TG

Tina Goldstein, PhD

Principal Investigator

University of Pittsburgh

PF

Peter Franzen

Principal Investigator

University of Pittsburgh

Are You a Good Fit for This Trial?

This trial is for college students at high risk of suicide who are fluent in English, have had suicidal thoughts or attempts in the past month, and suffer from significant sleep disturbances. They must be enrolled or planning to enroll in COSTAR Intensive Outpatient Program.

Inclusion Criteria

I am enrolled or planning to enroll in the COSTAR Intensive Outpatient Program.
I can read, write, and speak English well enough to follow study instructions.
I have not had thoughts of or attempted suicide in the past month.
See 1 more

What Are the Treatments Tested in This Trial?

Interventions

  • Sleep Feedback + Psychoeducation
  • Transdiagnostic Sleep and Circadian Intervention + Bright Light (TSC+)
  • Triple Chronotherapy (TCT+)

Trial Overview

The study tests three interventions: Triple Chronotherapy plus Transdiagnostic Sleep and Circadian Intervention (TCT+TSC), just TSC, and Sleep Feedback. These are added to standard psychiatric care for depression/suicide risk to see if they lower suicide risk over a 6-month period.

How Is the Trial Designed?

3

Treatment groups

Experimental Treatment

Group I: Triple Chronotherapy + Transdiagnostic Sleep and Circadian Intervention + Bright Light (TSC+)Experimental Treatment3 Interventions
Group II: Transdiagnostic Sleep and Circadian Intervention + Bright Light (TSC+)Experimental Treatment2 Interventions
Group III: Sleep Feedback + PsychoeducationExperimental Treatment1 Intervention

Find a Clinic Near You

Who Is Running the Clinical Trial?

University of Pittsburgh

Lead Sponsor

Trials
1,820
Recruited
16,360,000+

American Foundation for Suicide Prevention

Collaborator

Trials
36
Recruited
10,500+